These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 20017459)
1. Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Kuru O; Bilgici A; Birinci A; Ulusoy H; Durupinar B Bratisl Lek Listy; 2009; 110(10):650-4. PubMed ID: 20017459 [TBL] [Abstract][Full Text] [Related]
2. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Agrawal S; Misra R; Aggarwal A Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283 [TBL] [Abstract][Full Text] [Related]
4. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Forslind K; Ahlmén M; Eberhardt K; Hafström I; Svensson B; Ann Rheum Dis; 2004 Sep; 63(9):1090-5. PubMed ID: 15308518 [TBL] [Abstract][Full Text] [Related]
5. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044 [TBL] [Abstract][Full Text] [Related]
6. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
7. [Predictive values of anti-cyclic citrullinated peptide antibody, antikeratin antibody and rheumatoid factor in diagnosing articular erosions in patients with rheumatoid arthritis]. Xie QB; Yin G Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):508-12. PubMed ID: 19627016 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712 [TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis. Chang PY; Yang CT; Cheng CH; Yu KH Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989 [TBL] [Abstract][Full Text] [Related]
12. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. Jansen AL; van der Horst-Bruinsma I; van Schaardenburg D; van de Stadt RJ; de Koning MH; Dijkmans BA J Rheumatol; 2002 Oct; 29(10):2074-6. PubMed ID: 12375314 [TBL] [Abstract][Full Text] [Related]
14. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Quinn MA; Gough AK; Green MJ; Devlin J; Hensor EM; Greenstein A; Fraser A; Emery P Rheumatology (Oxford); 2006 Apr; 45(4):478-80. PubMed ID: 16287917 [TBL] [Abstract][Full Text] [Related]
15. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535 [TBL] [Abstract][Full Text] [Related]
16. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis. Maraina CH; Nurdayana AK; Rusni D; Azwany Y Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Vencovský J; Machácek S; Sedová L; Kafková J; Gatterová J; Pesáková V; Růzicková S Ann Rheum Dis; 2003 May; 62(5):427-30. PubMed ID: 12695154 [TBL] [Abstract][Full Text] [Related]
19. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus. Popescu C; Zofotă S; Bojincă V; Ionescu R Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631 [TBL] [Abstract][Full Text] [Related]
20. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis. Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]